PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+79.42%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$93.4M
AUM Growth
+$93.4M
(+11%)
Cap. Flow
-$3.76M
Cap. Flow
% of AUM
-4.03%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Ocular Therapeutix
OCUL
|
$3.76M |
Sector Composition
| 1 | Healthcare | 89.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cartesian Therapeutics
RNAC
$261M
| $27.6M | 29.5% | 1,924,151 | – | – |
|
2
Pulmatrix
PULM
$18M
| $12.6M | 13.48% | 3,607,996 | – | – |
|
|
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
| $12M | 12.83% | 1,968,606 | – | – |
|
4
Fate Therapeutics
FATE
$120M
| $11.3M | 12.05% | 2,473,186 | – | – |
|
|
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
| $9.87M | 10.56% | 1,875,524 | – | – |
|
|
TRVN
6
DELISTED
Trevena, Inc.
TRVN
| $7.54M | 8.07% | 2,053,540 | – | – |
|
|
ATYR
7
aTyr Pharma
ATYR
$527M
| $6.4M | 6.85% | 1,827,992 | – | – |
|
|
8
Ocular Therapeutix
OCUL
$2.12B
| $3.56M | 3.81% | 383,141 -405,582 | -51% | -$3.76M |
|
9
Dare Bioscience
DARE
$27.2M
| $2.67M | 2.86% | 3,287,529 | – | – |
|